Form 8-K - Current report:
SEC Accession No. 0001193125-20-324303
Filing Date
2020-12-22
Accepted
2020-12-22 13:52:00
Documents
13
Period of Report
2020-12-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d100755d8k.htm   iXBRL 8-K 24697
2 EX-99.1 d100755dex991.htm EX-99.1 54442
  Complete submission text file 0001193125-20-324303.txt   194871

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ck0000711377-20201222.xsd EX-101.SCH 3088
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0000711377-20201222_lab.xml EX-101.LAB 15319
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0000711377-20201222_pre.xml EX-101.PRE 9670
6 EXTRACTED XBRL INSTANCE DOCUMENT d100755d8k_htm.xml XML 2992
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 201407362
SIC: 2835 In Vitro & In Vivo Diagnostic Substances